Health
Diabetes vaccine gives promising results in a genetic subgroup – EurekAlert
A clinical study led by Linköping University, Sweden, and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type…
IMAGE: Johnny Ludvigsson, senior professor at Linköping University.
view more
Credit: Anna Nilsen/Linköping University
A clinical study led by Linköping University and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type 1 diabetes can preserve the body’s own production of insulin. The results suggest that injection of a protein, GAD, into lymph nodes can be effective in a subgroup of individuals. The results have been published in Diabetes Care.
…
-
Noosa News21 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News20 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
Noosa News19 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
General18 hours agoDairy farmers devastated by floods across parts of New South Wales